Clinical research and surgical treatment of Hashimoto's disease complicated with papillary thyroid carcinoma
-
摘要: 目的:通过对桥本病合并甲状腺乳头状癌的相关临床参数的研究分析,探讨桥本病对甲状腺乳头状癌侵袭性的影响及外科治疗。方法:回顾性分析312例甲状腺乳头状癌患者,其中包括70例桥本病合并甲状腺乳头状癌患者(观察组),242例单纯性甲状腺乳头状癌患者(对照组)。结果:观察组与对照组在性别、肿瘤大小、甲状腺抗体水平及中央区淋巴结转移方面差异有统计学意义(P<0.05)。结论:桥本病是甲状腺乳头状癌的一种保护性因素,合并桥本病的甲状腺乳头状癌病灶直径更小,有更低的淋巴结转移,对合并桥本病的甲状腺乳头状癌患者宜在采取手术原发灶根治的同时行中央区淋巴结清扫,尽量避免预防性颈侧淋巴结清扫。Abstract: Objective: To analyze the clinical characteristics of Hashimoto's disease complicated with papillary thyroid carcinoma and research surgical treatment and Hashimoto's disease's effect to papillary thyroid carcinoma.Method: Three hundred and twelve cases of papillary thyroid carcinoma were retrospectively reviewed. Among 70 cases of papillary thyroid carcinoma associated Hashimoto's disease(the observation group), 242 cases of single papillary thyroid carcinoma(the control group).Result: The observation group compared with the control group,there was a significant difference in gender, tumor size, thyroid antibody level and the lymph node metastasis, with statistical significance (P<0.05).Conclusion: Hashimoto's disease is a kind of protective factors of thyroid papillary carcinoma, Hashimoto's disease with coexistent papillary thyroid carcinoma is smaller in tumor diameter and have lower lymph node metastasis.Surgery takes the original operation primary radical and central lymph node dissection, try to avoid the preventive side neck lymph node dissection.
-
Key words:
- Hashimoto's disease /
- thyroid neoplasms /
- surgical treatment
-
[1] LIOTTI F,VISCIANO C,MELILLO R M.Inflammation in thyroid oncogenesis[J].Am J Cancer Res,2012,2:286-297.
[2] HANAHAN D,WEINBERG R A.Hallmarks of cancer:the next generation[J].Cell,2011,144:646-741.
[3] LARSON S D,JACKSON L N,RIALL T S,et al.Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway[J].J Am Coll Surg,2007,204:764-773.
[4] CUNHA L L,FERREIRA R C,MARCELLO M A,et al.Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroidcancer[J].J Thyroid Res,2011,17:387062-387062.
[5] HAYMART M R,REPPLINGER D J,LEVERSON G E,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,11:809-814.
[6] ZHANG L,LI H,JI Q H,et al.The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a highprevalence of Hashimoto's disease[J].BMC Cancer,2012,12:610-610.
[7] 吴恋,于建春,康维明,等.碘营养状况与甲状腺疾病[J].中国医学科学院学报,2013,35(4):363-368.
[8] KIM Y S,CHOI H J,KIM E S.Papillary thyroid carcinoma with thyroiditis:lymph node metastasis,complications[J].J Korean Surg Soc,2013,85:20-24.
[9] LEE J H,KIM Y,CHOI J W,et al.The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis:a meta-analysis[J].Eur J Endocrinol,2013,168:343-349.
[10] KIM S S,LEE B J,LEE J C.Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma:the influence of lymph node metastasis[J].Head Neck,2011,33:1272-1277.
计量
- 文章访问数: 27
- PDF下载数: 47
- 施引文献: 0